UK markets closed

ACADIA Pharmaceuticals Inc. (DR6.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
14.24-1.57 (-9.90%)
At close: 08:07AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 2.34B
Enterprise value 1.96B
Trailing P/E N/A
Forward P/E 23.64
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.11
Price/book (mrq)5.47
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.42
52-week change 3-27.32%
S&P500 52-week change 326.27%
52-week high 329.40
52-week low 314.24
50-day moving average 317.12
200-day moving average 321.88

Share statistics

Avg vol (3-month) 38
Avg vol (10-day) 3N/A
Shares outstanding 5165.22M
Implied shares outstanding 6168.9M
Float 8110.07M
% held by insiders 10.49%
% held by institutions 1100.33%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.21%
Operating margin (ttm)7.39%

Management effectiveness

Return on assets (ttm)-0.38%
Return on equity (ttm)-0.41%

Income statement

Revenue (ttm)813.81M
Revenue per share (ttm)4.95
Quarterly revenue growth (yoy)73.80%
Gross profit (ttm)N/A
EBITDA 1.93M
Net income avi to common (ttm)-1.71M
Diluted EPS (ttm)0.00
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)470.52M
Total cash per share (mrq)2.86
Total debt (mrq)49.19M
Total debt/equity (mrq)10.60%
Current ratio (mrq)2.04
Book value per share (mrq)2.82

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A